KLEEMANN, Rainer,TROETSCHEL, Christian,VOLLMAR, Andrea
申请号：
DK06829958
公开号：
DK1951227T3
申请日:
2006.11.08
申请国别(地区):
DK
年份:
2017
代理人:
摘要：
The invention relates to the use of a phosphodiesterase type III (PDE III) inhibitor and/or Ca 2+ -sensitizing agent or a pharmaceutically acceptable derivative thereof for the preparation of a medication for the prolongation of time until onset of clinical symptoms in patients having an asymptomatic (occult) heart failure and/or for the reduction of heart size in patients having an asymptomatic (occult) heart failure.
